Moderna swings to profit, but the stock is down 6.55%
Moderna fell 6.55% to $241.46 despite a WSJ report of a swing to profit; the tracked sources did not explain the drop.
What's happening
WSJ reports Moderna swung to a profit and lifted its outlook as Covid-19 vaccine demand stabilizes. The only other item is a personal Mastodon post about getting a Moderna shot, which does not discuss the company's finances. The tracked sources do not explain why the shares fell on the day.
The numbers
MRNA closed at $241.46 on 2026-11-05, the latest close in the data on or before the story day, after a 6.55% drop. Chatter shows a velocity of 8.8 across 3 source types, with 10 recent mentions.
Our read
The chatter is real but shallow, and the price is moving the wrong way against a positive headline. Money is not backing the story today, so this reads as fake hot. The evidence does not say why the shares fell, so we won't guess. Watch whether the drop holds or reverses once investors digest the raised outlook.
Context
On the story day, MRNA sat 76% of the way up its 30-day range, which runs from $187.46 to $258.38. Over 90 days it sat 92% of the way up a range of $59.17 to $258.38, and it rose 308.1% from the start of that window. Earlier Sort Brick Moderna stories were: 2026-08-19 (watch, melanoma vaccine trial chatter), 2026-10-06 (real, cancer vaccine data that doubled the stock), 2026-10-23 (real, a drop of as much as 26% on a reported leak), 2026-10-23 (fake, loud leak chatter with a 1.5% gain), and 2026-10-24 (fake, $24 billion shed as cancer vaccine data was sold). No later Sort Brick stories are listed, and the data contains no price rows after the story day.
Sources we checked
- Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes — WSJ
- I have Moderna shot in my left arm, and flu shot in my right arm. — @chemoelectric@masto.ai
See today's live board
This story is frozen as published on November 7, 2026. The live board shows what is moving right now, scored against real money.
Open this story live → See today's live boardEarlier on Moderna
- Moderna sheds $24 billion as cancer vaccine data is sold October 24, 2026
- Moderna Leak Chatter Is Loud, but Price Shows Only a 1.5% Gain October 23, 2026
- Moderna drops as much as 26% on reported cancer vaccine data leak October 23, 2026
- Moderna's cancer vaccine data just doubled the stock October 6, 2026
- Moderna's Melanoma Vaccine Trial Ignites Chatter August 19, 2026
More Stocks stories
- Tesla ends Cybertruck as Musk's net worth reportedly drops $80 billion November 7, 2026
- Meta chatter is thin and the price data is a mismatch November 7, 2026
- Google takes Crusoe's troubled Wyoming data center site November 7, 2026
- TSMC weighs memory chips at Nvidia's request as Asian chips slide November 7, 2026
- Riot jumps 13% on a $28B AI lease naming Anthropic as tenant November 7, 2026
- Unity jumps 15% with nothing in the evidence to explain it November 7, 2026
Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything — you decide.